Literature DB >> 11124717

Antiarrhythmic drugs in pregnancy.

J A Joglar1, R L Page.   

Abstract

During pregnancy a number of rhythm disturbances can occur in both the mother and fetus; these may range from benign ectopy to life-threatening arrhythmias. With a clear understanding of the maternal hemodynamic changes associated with pregnancy, and the appropriate antiarrhythmic therapies available, almost all such cases can be treated successfully. Although no drug is completely safe, most are well tolerated and can be given with relatively low risk. Drug therapy should be avoided during the first trimester of pregnancy if possible and drugs with the longest record of safety should be used as first-line therapy. Conservative therapies should be used when appropriate. Several drug options exist for most maternal and fetal arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11124717     DOI: 10.1097/00001573-200101000-00006

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  10 in total

1.  Drugs in pregnancy: Implications for a cardiologist.

Authors:  Karel Rakusan
Journal:  Exp Clin Cardiol       Date:  2010

Review 2.  Antiarrhythmic drugs-safety and efficacy during pregnancy.

Authors:  Alicia Jeanette Fischer; Gerhard-Paul Diller; Anselm Uebing; Jan-Hendrik Nürnberg; Joachim Hebe
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-03-29

3.  Pharmacological Therapy of Tachyarrhythmias During Pregnancy.

Authors:  Ameeta Yaksh; Lisette Jme van der Does; Eva Ah Lanters; Natasja Ms de Groot
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

4.  Transplacental pharmacokinetics of flecainide in the gravid baboon and fetus.

Authors:  V V Dimas; V V Dimasc; M D Taylor; C B Cunnyngham; E D Overholt; D W A Bourne; J R Stanely; A Sheikh; R Wolf; B Valentine; K E Ward
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

5.  Atrial fibrillation with a structurally normal heart in pregnancy: An international survey on current practice.

Authors:  Annabelle Cumyn; Nadine Sauvé; Évelyne Rey
Journal:  Obstet Med       Date:  2017-01-29

6.  Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardiaca y Electrofisiologia (SOLAECE).

Authors:  Demosthenes G Katritsis; Giuseppe Boriani; Francisco G Cosio; Pierre Jais; Gerhard Hindricks; Mark E Josephson; Roberto Keegan; Bradley P Knight; Karl-Heinz Kuck; Deirdre A Lane; Gregory Yh Lip; Helena Malmborg; Hakan Oral; Carlo Pappone; Sakis Themistoclakis; Kathryn A Wood; Kim Young-Hoon; Carina Blomström Lundqvist
Journal:  Arrhythm Electrophysiol Rev       Date:  2016

7.  Syncope in a pregnant woman with repaired Tetralogy of Fallot: a case report.

Authors:  Nare Ghazaryan; Miqayel Adamyan; Lianna Khachatryan; Tatevik Hovakimyan
Journal:  Eur Heart J Case Rep       Date:  2022-05-24

8.  Ventricular tachycardia in pregnant patients.

Authors:  Rouslan Kotchetkov; Ameen Patel; Omid Salehian
Journal:  Clin Med Insights Cardiol       Date:  2010-05-17

Review 9.  Adult Congenital Heart Disease with Pregnancy.

Authors:  Koichiro Niwa
Journal:  Korean Circ J       Date:  2018-04       Impact factor: 3.243

Review 10.  Zero-fluoroscopy catheter ablation of severe drug-resistant arrhythmia guided by Ensite NavX system during pregnancy: Two case reports and literature review.

Authors:  Guangzhi Chen; Ge Sun; Renfan Xu; Xiaomei Chen; Li Yang; Yang Bai; Shanshan Yang; Ping Guo; Yan Zhang; Chunxia Zhao; Dao Wen Wang; Yan Wang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.